HUTCHMED (China) Limited (AIM:HCM)
240.00
+2.00 (0.84%)
Mar 11, 2025, 5:15 PM GMT+1
HUTCHMED (China) Revenue
HUTCHMED (China) had revenue of $305.68M USD in the half year ending June 30, 2024, with 51.29% growth. This brings the company's revenue in the last twelve months to $610.81M, down -19.34% year-over-year. In the year 2023, HUTCHMED (China) had annual revenue of $838.00M with 96.52% growth.
Revenue (ttm)
$610.81M
Revenue Growth
-19.34%
P/S Ratio
4.21
Revenue / Employee
$307.25K
Employees
1,988
Market Cap
2.03B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 838.00M | 411.59M | 96.52% |
Dec 31, 2022 | 426.41M | 70.28M | 19.73% |
Dec 31, 2021 | 356.13M | 128.15M | 56.21% |
Dec 31, 2020 | 227.98M | 23.09M | 11.27% |
Dec 31, 2019 | 204.89M | -9.22M | -4.31% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
Genus | 671.60M |
Oxford Nanopore Technologies | 183.19M |
HUTCHMED (China) News
- 5 days ago - HUTCHMED Completes Enrollment for Phase II Trial of Fanregratinib in IHCC Patients - GuruFocus
- 5 days ago - HUTCHMED Announces that it has Completed Enrollment of a Phase II Registration Study of Fanregratinib (HMPL-453) for Intrahepatic Cholangiocarcinoma in China - GlobeNewsWire
- 6 days ago - HUTCHMED (China) Ltd (HCM) Appoints Alvin Wong as Independent Non-Executive Director - GuruFocus
- 6 days ago - HUTCHMED Appoints Alvin Wong as Independent Non-Executive Director - GuruFocus
- 6 days ago - HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee - GlobeNewsWire
- 19 days ago - HUTCHMED (China) Ltd (HCM) Announces Upcoming Financial Results Release - GuruFocus
- 20 days ago - HUTCHMED to Announce 2024 Final Results - GlobeNewsWire
- 5 weeks ago - Despite A Promising Future For Hutchmed, We Have Concerns About Development Of The Share Price (Rating Downgrade) - Seeking Alpha